 <h1>Orencia Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>abatacept</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about abatacept. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Orencia.</p><h2>In Summary</h2><p><b>Common side effects of Orencia include:</b> headache and nasopharyngitis. <b>Other side effects include:</b> dyspepsia and hypertension.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to abatacept: powder for solution, solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, abatacept (the active ingredient contained in Orencia) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking abatacept:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>bladder pain</li>
<li>bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>difficult, burning, or painful urination</li>
<li>difficult or labored breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>nausea or vomiting</li>
<li>noisy breathing</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stuffy or runny nose</li>
<li>tightness of the chest</li>
<li>trouble breathing</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>burning or stinging of the skin</li>
<li>chest pain</li>
<li>nervousness</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>pounding in the ears</li>
<li>skin rash</li>
<li>slow or fast heartbeat</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Confusion</li>
<li>difficulty with swallowing</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>flushing</li>
<li>hives or welts</li>
<li>itching, pain, redness, swelling, tenderness, or warmth on the skin</li>
<li>stomach pain or tenderness</li>
<li>sweating</li>
<li>swelling of the face, throat, or tongue</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Redness, soreness, or itching of the skin</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>sores, welts, blisters</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of abatacept may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>heartburn</li>
<li>indigestion</li>
<li>stomach discomfort or upset</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>pain in the arms or legs</li>
</ul><p>
<!-- end powder for solution, solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to abatacept: intravenous powder for injection, subcutaneous solution</i></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (including tracheitis, nasopharyngitis)</p>
<p><b>Common</b> (1% to 10%): Lower respiratory tract infection (including bronchitis), rhinitis, pneumonia, cough, sinusitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, wheezing, dyspnea</p>
<p><b>Rare</b> (less than 0.1%): Throat tightness, bacterial pneumonia, influenza pneumonia</p>
<p><b>Frequency not reported</b>: Tracheitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Cancer of lung, skin, breast, bile duct, bladder, cervical, endometrial, lymphoma, melanoma, myelodysplastic syndrome, ovarian, prostate, renal, thyroid, uterus<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Herpes infections (including herpes simplex, oral herpes, and herpes zoster), influenza</p>
<p><b>Uncommon</b> (0.1% to 1%): Streptococcal sepsis</p>
<p><b>Rare</b> (less than 0.1%): Tuberculosis, bacteremia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, nausea, dyspepsia, mouth ulceration, aphthous stomatitis, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Tooth infection, gastritis, weight increased</p>
<p><b>Rare</b> (less than 0.1%): Gastrointestinal infection, diverticulitis, peridiverticular abscess<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Pelvic inflammatory disease, amenorrhea, menorrhagia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (including dermatitis), alopecia, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Onychomycosis, skin abscess</p>
<p><b>Frequency not reported</b>: Dry skin, cellulitis, increased tendency to bruise, infected skin ulcers<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (12%) </p>
<p><b>Common</b> (1% to 10%): Dizziness, paresthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Migraine</p>
<p><b>Frequency not reported</b>: Vertigo<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local injection site reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Palpitations, tachycardia, bradycardia, hypotension, hot flush, vasculitis, hypotension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function test abnormal (including transaminases increased)</p>
<p><b>Frequency not reported</b>: abnormal liver function tests and increased transaminases<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leukopenia </p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Weight gain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity</p>
<p><b>Uncommon</b> (0.1% to 1%): Musculoskeletal infections, arthralgia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry eye, visual acuity reduced<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression, anxiety, sleep disorder (including insomnia)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Pyelonephritis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Gartlehner G,  Hansen RA,  Jonas BL,  Thieda P,  Lohr KN "The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis." J Rheumatol 33 (2006): 2398-408</p><p id="ref_2">2. Genovese MC,  Becker JC,  Schiff M, et al. "Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition." N Engl J Med 353 (2005): 1114-23</p><p id="ref_3">3. Nogid A,  Pham DQ "Role of abatacept in the management of rheumatoid arthritis." Clin Ther 28 (2006): 1764-78</p><p id="ref_4">4. "Product Information. Orencia (abatacept)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_6">6. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Orencia (abatacept)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>49 Reviews</li>
<li>Drug class: antirheumatics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Orencia &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Rheumatoid Arthritis</li>
<li>Psoriatic Arthritis</li>
<li>Juvenile Idiopathic Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to abatacept: intravenous powder for injection, subcutaneous solution</i></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (including tracheitis, nasopharyngitis)</p><p><b>Common</b> (1% to 10%): Lower respiratory tract infection (including bronchitis), rhinitis, pneumonia, cough, sinusitis</p><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, wheezing, dyspnea</p><p><b>Rare</b> (less than 0.1%): Throat tightness, bacterial pneumonia, influenza pneumonia</p><p><b>Frequency not reported</b>: Tracheitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Cancer of lung, skin, breast, bile duct, bladder, cervical, endometrial, lymphoma, melanoma, myelodysplastic syndrome, ovarian, prostate, renal, thyroid, uterus<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Herpes infections (including herpes simplex, oral herpes, and herpes zoster), influenza</p><p><b>Uncommon</b> (0.1% to 1%): Streptococcal sepsis</p><p><b>Rare</b> (less than 0.1%): Tuberculosis, bacteremia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, diarrhea, nausea, dyspepsia, mouth ulceration, aphthous stomatitis, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Tooth infection, gastritis, weight increased</p><p><b>Rare</b> (less than 0.1%): Gastrointestinal infection, diverticulitis, peridiverticular abscess<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Pelvic inflammatory disease, amenorrhea, menorrhagia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (including dermatitis), alopecia, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Onychomycosis, skin abscess</p><p><b>Frequency not reported</b>: Dry skin, cellulitis, increased tendency to bruise, infected skin ulcers<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (12%) </p><p><b>Common</b> (1% to 10%): Dizziness, paresthesia</p><p><b>Uncommon</b> (0.1% to 1%): Migraine</p><p><b>Frequency not reported</b>: Vertigo<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local injection site reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Palpitations, tachycardia, bradycardia, hypotension, hot flush, vasculitis, hypotension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function test abnormal (including transaminases increased)</p><p><b>Frequency not reported</b>: abnormal liver function tests and increased transaminases<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leukopenia </p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Weight gain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain in extremity</p><p><b>Uncommon</b> (0.1% to 1%): Musculoskeletal infections, arthralgia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis</p><p><b>Uncommon</b> (0.1% to 1%): Dry eye, visual acuity reduced<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Depression, anxiety, sleep disorder (including insomnia)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Pyelonephritis<sup>[Ref]</sup></p><p id="ref_1">1. Gartlehner G,  Hansen RA,  Jonas BL,  Thieda P,  Lohr KN "The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis." J Rheumatol 33 (2006): 2398-408</p><p id="ref_2">2. Genovese MC,  Becker JC,  Schiff M, et al. "Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition." N Engl J Med 353 (2005): 1114-23</p><p id="ref_3">3. Nogid A,  Pham DQ "Role of abatacept in the management of rheumatoid arthritis." Clin Ther 28 (2006): 1764-78</p><p id="ref_4">4. "Product Information. Orencia (abatacept)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_5">5. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_6">6. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul><h2>More about Orencia (abatacept)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>49 Reviews</li>
<li>Drug class: antirheumatics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Orencia &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Rheumatoid Arthritis</li>
<li>Psoriatic Arthritis</li>
<li>Juvenile Idiopathic Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>